Modulation of tamoxifeninduced apoptosis of ERnegative breast cancer cells by Bcl2 and Caspase3
Author:
Affiliation:

Clc Number:

R737.9; Q329.25

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Objective:To explore the role of Bcl2 and Caspase3 in modulating apoptosis of ERnegative breast cancer cells induced by tamoxifen. Methods:ERnegative breast cancer cell lines MDAMB231 were treated with 10.0μM tamoxifen for 12, 24, 36、48, 60 hours. The rate of cell apoptosis with or without caspase3 inhibitor AcDEVDCHO, and protein expression of Bcl2,Bax were determined by flow cytometry, and the activity of Caspase3 was examined with fluorophotometry. Results:The expression of Bcl2 was downregulated, the activity of Caspase3 and the rate of cell apoptosis were increased by TAM timedependently, and the rate of apoptosis reached its peak at 48 hours. The expression of Bcl2 was negatively correlated with activity of caspase3. Tamoxifen, however, did not affect Bax protein expression. AcDEVDCHO, a caspase3 inhibitor, blocked the activation of caspase3 and inhibited cell apoptosis induced by tamoxifen. Conclusions:TAM could induce apoptosis in ERnegative breast cancer cells via mitochondria pathway by downregulating Bcl2 expression, and the activation of Caspase3 might play an important role in the process of tamoxifeninduced apoptosis of ERnegative breast cancer cells.

    Reference
    Related
    Cited by
Get Citation

GAO Dezong, SUN Jingzhong, LI Yonggang, SHAO Lihua, LI Jintao .Modulation of tamoxifeninduced apoptosis of ERnegative breast cancer cells by Bcl2 and Caspase3[J]. Chin J Gen Surg,2005,14(9):14-.
DOI:10.7659/j. issn.1005-6947.2005.09.014

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:January 01,1900
  • Revised:January 01,1900
  • Adopted:
  • Online: September 25,2005
  • Published: